CardioSignal
PrivateLast Round
Series A
Jan 23, 2024
Total Funding Raised
$17.26M
Company Overview
CardioSignal operates in Healthcare & Life Sciences and is based in Turku. Its latest recorded funding round was a Series A round in January 2024.
CardioSignal is a healthcare technology company that develops digital cardiac biomarkers for self-monitoring, remote care, and point-of-care diagnostics using smartphone motion sensors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Health IoT
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioSignal Comparables
Compare CardioSignal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qompium | 87% | |
| Preventicus | 81% | |
| Acculi Labs | 78% |
For institutional investors. Book with your work email.
CardioSignal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 23, 2024 | ||||
| Seed | Sep 30, 2021 | ||||
| Seed | Jun 1, 2020 | ||||
| Grant | Mar 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CardioSignal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DigiTx Partners | Series A |
| European Commission | Grant |
| Sandwater | Series A |
| Maki | Series A, Seed |
| European Union | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 83% MoM.
- Apr 16, 2026
Monthly visitors increased 138% MoM.
For institutional investors. Book with your work email.
CardioSignal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardioSignal's valuation, stock price, and market status.
Is CardioSignal a public or private company?
CardioSignal is a private company.
What is the current stock price of CardioSignal?
CardioSignal is a private company, so its shares have no public market price. Caplight tracks CardioSignal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardioSignal worth (valuation)?
Valuation information for CardioSignal is not publicly available.
Can I buy CardioSignal stock?
CardioSignal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardioSignal's last funding round?
CardioSignal's most recent funding round was Series A on January 23, 2024.
Who are the main investors in CardioSignal?
Key investors in CardioSignal include DigiTx Partners, Maki.
Will CardioSignal IPO soon?
No public IPO plans have been announced for CardioSignal.
How can I track CardioSignal secondary market activity?
Caplight tracks bids, offers, and trades in CardioSignal's shares on secondary markets.